IMMUPARKNET, the leading network dedicated to researching the role of immunity and neuroinflammation in Parkinson’s Disease, proudly announces the participation of its prominent members at...
For more than 20 years, the Dopamine Meetings have provided a collaborative forum for scientists from diverse backgrounds to share their latest work and ideas....
📍 Faculty of Medicine, University of Coimbra (FMUC), Portugal📅 12–14 June 2026 We are pleased to present the final program of the 4th and final...
Seville, 9–10 April 2026 The second edition of the IMMUPARKNET Training School was held at the Instituto de Biomedicina de Sevilla (IBiS) in Seville, Spain,...
A new study published in “The Lancet Neurology” investigates whether azathioprine, a common immunosuppressant, could represent a breakthrough in slowing the progression of Parkinson’s Disease...
We are pleased to announce that the fourth and final Annual Conference of the IMMUPARKNET Action will take place in Coimbra, Portugal, from 12 to...
We are pleased to announce that the call for grant applications for Grant Period 4 of ImmuParkNet is now open. This call covers activities to...